Inventor · disambiguated record
Kirk Willis Johnson
Also filed as: JOHNSON KIRK W · JOHNSON KIRK WILLIS
16 granted patents·3 pending applications·4,426 citations·filing 1990–2021
95Inventor score
Top patents by PatentIndex Score
19 records- 0199US5411647ATechniques to improve the performance of electrochemical sensorsLILLY CO ELI·Filed 1994·Granted May 2, 1995·1.6k cites·31 claims
- 0298US5108819AThin film electrical componentLILLY CO ELI·Filed 1990·Granted Apr 28, 1992·941 cites·19 claims
- 0395US5322063AHydrophilic polyurethane membranes for electrochemical glucose sensorsLILLY CO ELI·Filed 1991·Granted Jun 21, 1994·1.6k cites·15 claims
- 0484US5817671A5-HT1F agonistsLILLY CO ELI·Filed 1997·Granted Oct 6, 1998·50 cites·13 claims
- 0582US5166063AImmobolization of biomolecules by enhanced electrophoretic precipitationLILLY CO ELI·Filed 1990·Granted Nov 24, 1992·96 cites·8 claims
- 0679US5698571A5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraineLILLY CO ELI·Filed 1994·Granted Dec 16, 1997·36 cites·20 claims
- 0778US6380201B1Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonistsLILLY CO ELI·Filed 1999·Granted Apr 30, 2002·21 cites·3 claims
- 0877US6800651B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2001·Granted Oct 5, 2004·11 cites·30 claims
- 0973US6566370B1Selective iGluR5 receptor antagonists for the treatment of migraineLILLY CO ELI·Filed 2000·Granted May 20, 2003·5 cites·16 claims
- 1071US2022112277A1Anti-CGRP Antibody FormulationLILLY CO ELI·Filed 2021·Application pending·0 cites
- 1169US5744482ASerotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraineLILLY CO ELI·Filed 1994·Granted Apr 28, 1998·34 cites·5 claims
- 1265US5962473AMethods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1FLILLY CO ELI·Filed 1997·Granted Oct 5, 1999·20 cites·2 claims
- 1358US12138254B2Chronic nightly dosing of lasmiditan for migraine preventionLILLY CO ELI·Filed 2019·Granted Nov 12, 2024·0 cites·10 claims
- 1444US5886003AMethods of treating or ameliorating the symptoms of venomous bites and stingsLILLY CO ELI·Filed 1997·Granted Mar 23, 1999·7 cites·11 claims
- 1544US2020268735A1Combination Therapy of Lasmiditan and a CGRP Antagonist for Use in the Treatment of MigraineLILLY CO ELI·Filed 2018·Application pending·0 cites
- 1639US5869497AMethod of treating or ameliorating the symptoms of common cold or allergic rhinitisLILLY CO ELI·Filed 1997·Granted Feb 9, 1999·4 cites·8 claims
- 1734US2010028296A1Use of cytokine-derived peptides in treatment of pain and neurodegenerative diseaseCHAVEZ RAYMOND A·Filed 2006·Application pending·0 cites
- 1832US5998622A5-HT1F agonists intermediatesLILLY CO ELI·Filed 1998·Granted Dec 7, 1999·0 cites·2 claims
- 1932US5919936ANitropyridine compoundLILLY CO ELI·Filed 1998·Granted Jul 6, 1999·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Kirk Willis Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →